Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery

Yan Wang, Ying Xie, David Oupický

Research output: Contribution to journalReview articlepeer-review

51 Scopus citations


This review discusses the potential of CXCR4 chemokine receptor in the design of anticancer and antimetastatic drug delivery systems. The role of CXCR4 in cancer progression and metastasis is discussed in the context of the development of several types of drug delivery strategies. Overview of drug delivery systems targeted to cancers that overexpress CXCR4 is provided, together with the main types of CXCR4-binding ligands used in targeting applications. Drug delivery applications that take advantage of CXCR4 inhibition to achieve enhanced anticancer and antimetastatic activity of combination treatments are also discussed.

Original languageEnglish (US)
JournalCurrent Pharmacology Reports
Issue number1
StatePublished - Feb 1 2016


  • CXCR4
  • Cancer
  • Drug delivery
  • Gene delivery
  • Metastasis
  • Nanoparticles
  • siRNA delivery

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery'. Together they form a unique fingerprint.

Cite this